Metropolis Healthcare - Inorganic Foray into Non-Core Markets; Scalability Key Monitorable
MHL announced its acquisition of Core Diagnostics—an oncology focused diagnostics chain with majority of its revenue derived from North/East India—...
320 Views
Metropolis Healthcare: Core Diagnostic M&A to Strengthen Speciality Portfolio.
Metropolis signed a definite agreement to acquire a 100% stake in Core Diagnostics. This acquisition will strengthen its advanced cancer testing...
453 Views
Suraksha Diagnostic IPO: Premium Valuation Limits Near-Term Upside Potential
​Suraksha Diagnostic offers integrated pathology and radiology services in India. The IPO comprises of an OFS of up to 19M shares. The company has...
713 Views
Metropolis Healthcare - Tier 3 Expansion and Wellness Portfolio to Drive Revenue Growth
MHL’s Q2FY25 print was in line with our estimates, with revenues growing 13% YoY, driven by B2C revenues improving 21% YoY.
233 Views
Dr Lal PathLabs Ltd (DLPL IN): Poised for Next Level of Growth Amid Easing Price Competition
​Dr Lal PathLabs expects 10% revenue growth fueled by patient volume in FY25. The company is looking for small or mid-sized acquisitions in South...
624 Views